Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$19,402,026
-$2,976,386 QoQ
Shares Held
805,732
+1.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#296
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sound Income Strategies, LLC holds $77,276,482 across 11 Drug Manufacturers - General names. PFE ranks #2 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
96,903 | $24,384,670 | |
| 2 | PFE |
Pfizer Inc
This page
|
805,732 | $19,402,026 | |
| 3 | GSK |
GSK plc
|
339,055 | $17,773,263 | |
| 4 | LLY |
ELI LILLY & Co
|
5,822 | $6,983,082 | |
| 5 | SNY |
Sanofi
|
90,957 | $3,880,225 | |
| 6 | JNJ |
Johnson & Johnson
|
9,354 | $2,375,635 | |
| 7 | AMGN |
Amgen Inc
|
2,246 | $813,321 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,917 | $631,834 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,402,026 | 805,732 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $22,378,412 | 796,952 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $20,160,110 | 809,643 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $20,844,270 | 818,064 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $20,314,792 | 838,069 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $20,042,749 | 790,953 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $20,290,727 | 764,822 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $20,125,049 | 695,406 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $18,537,869 | 662,540 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $17,069,496 | 615,117 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $12,279,769 | 426,529 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $13,080,622 | 394,351 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $11,777,287 | 321,082 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $10,738,927 | 263,209 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $12,217,563 | 238,438 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $9,515,043 | 217,437 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $12,351,669 | 235,584 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $11,255,574 | 217,415 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $11,345,571 | 192,135 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $8,980,574 | 208,802 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $7,172,702 | 183,164 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $5,880,020 | 162,297 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,408,954 | 119,776 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $3,267,250 | 89,026 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,569,143 | 78,567 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $2,258,978 | 69,209 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||